Fol. Biol. 2011, 57, 87-95
https://doi.org/10.14712/fb2011057030087
Unfolded Protein Response Suppresses Cisplatin-Induced Apoptosis via Autophagy Regulation in Human Hepatocellular Carcinoma Cells
References
1. 2008) Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 68, 1485-1494.
< , A., Herr, I., Schwarz, H., Rodemann, H. P., Mayer, A. (https://doi.org/10.1158/0008-5472.CAN-07-0562>
2. 2007) The cellular “networking” of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv. Exp. Med. Biol. 594, 14-26.
< , A. P. (https://doi.org/10.1007/978-0-387-39975-1_2>
3. 2005) Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6, 505-510.
< , E. H. (https://doi.org/10.1038/nrm1666>
4. 2004) Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs. Oncol. Rep. 11, 559-595.
, T., Vougiouka, M. (
5. 2007) Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110, 313-322.
< , J. S., Nawrocki, S. T., Kahue, C. N., Zhang, H., Yang, C., Chung, L., Houghton, J. A., Huang, P., Giles, F. J., Cleveland, J. L. (https://doi.org/10.1182/blood-2006-10-050260>
6. 2009) Role and regulation of autophagy in cancer. Biochim. Biophys. Acta 1793, 1516-1523.
< , N., Karantza-Wadsworth, V. (https://doi.org/10.1016/j.bbamcr.2008.12.013>
7. 2009) p28GANK inhibits endoplasmic reticulum stressinduced cell death via enhancement of the endoplasmic reticulum adaptive capacity. Cell Res. 19, 1243-1257.
< , R. Y., Chen, Y., Fu, J., Dong, L. W., Ren, Y. B., Yang, G. Z., Qian, Y. W., Cao, J., Tang, S. H., Yang, S. L., Wang, H. Y. (https://doi.org/10.1038/cr.2009.104>
8. 2007) Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem. 282, 4702-4710.
< , W. X., Ni, H. M., Gao, W., Hou, Y. F., Melan, M. A., Chen, X., Stolz, D. B., Shao, Z. M., Yin, X. M. (https://doi.org/10.1074/jbc.M609267200>
9. 1997) HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res. 57, 2661-2667.
, C., Ottavi, P., Fromentin, A., Hammann, A., Arrigo, A. P., Chauffert, B., Mehlen, P. (
10. 1992) Protein folding in the cell. Nature 355, 33-45.
< , M. J., Sambrook, J. (https://doi.org/10.1038/355033a0>
11. 2005) Identification of new genes involved in cisplatin resistance and their expression profile in 18 human tumor cell lines. Int. J. Clin. Pharmacol. Ther. 43, 579-580.
< , E. M., Weykam, S., Wiese, M., Kassack, M. U. (https://doi.org/10.5414/CPP43579>
12. 2010) HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1 α-XBP1 signaling through a physical interaction. PLoS Biol. 8, e1000410.
< , S., Deepti, A., Deegan, S., Lisbona, F., Hetz, C., Samali, A. (https://doi.org/10.1371/journal.pbio.1000410>
13. 2008) Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells. Biochem. Biophys. Res. Commun. 370, 123-128.
< , S., Nakashiro, K., Goda, H., Hamakawa, H. (https://doi.org/10.1016/j.bbrc.2008.03.042>
14. 1999) Protein translation and folding are coupled by an endoplasmic reticulum resident kinase. Nature 397, 271-274.
< , H. P., Zhang, Y., Ron, D. (https://doi.org/10.1038/16729>
15. 2002) Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18, 575-599.
< , H. P., Calfon, M., Urano, F., Novoa, I., Ron, D. (https://doi.org/10.1146/annurev.cellbio.18.011402.160624>
16. 2004) The ER function BiP is a master regulator of ER function. Mt. Sinai J. Med. 71, 289-297.
, L. M. (
17. 2004) Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279, 49420-49429.
< , P., Han, Z., Couvillon, A. D., Exton, J. H. (https://doi.org/10.1074/jbc.M407700200>
18. 2007) Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 1, 53-60.
< , D., de Thonel, A., Maurel, S., Didelot, C., Garrido, C. (https://doi.org/10.4161/pri.1.1.4059>
19. 2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6, 463-477.
< , B., Klionsky, D. J. (https://doi.org/10.1016/S1534-5807(04)00099-1>
20. 2006) Stress induction of GRP78/BiP and its role in cancer. Curr. Mol. Med. 6, 45-54.
< , J., Lee, A. S. (https://doi.org/10.2174/156652406775574523>
21. 2005) Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6, 439-448.
< , J. J., DeBerardinis, R. J., Thompson, C. B. (https://doi.org/10.1038/nrm1660>
22. 2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278, 9100-9106.
< , A., Hansson, J., Linder, S., Shoshan, M. C. (https://doi.org/10.1074/jbc.M210284200>
23. 2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101, 451-454.
< , K. (https://doi.org/10.1016/S0092-8674(00)80855-7>
24. 2006) Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell Biol. 26, 9220-9231.
< , M., Hino, S., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., Shiosaka, S., Hammarback, J. A., Urano, F., Imaizumi, K. (https://doi.org/10.1128/MCB.01453-06>
25. 2006) Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem. 13, 1859-1876.
< , R. (https://doi.org/10.2174/092986706777585077>
26. 2007) Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys. Toxicol. Sci. 99, 346-353.
< , M., Hanna, P. E., Cribb, A. E. (https://doi.org/10.1093/toxsci/kfm152>
27. 2004) A trip to the ER: coping with stress. Trends Cell Biol. 14, 20-28.
< , D. T., Kaufman, R. J. (https://doi.org/10.1016/j.tcb.2003.11.001>
28. 2005) ER stress and the unfolded protein response. Mutat. Res. 569, 29-63.
< , M., Kaufman, R. J. (https://doi.org/10.1016/j.mrfmmm.2004.06.056>
29. 2009) Targeted therapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 6, 423-432.
< , H. C., Thimme, R., Blum, H. E. (https://doi.org/10.1038/nrgastro.2009.86>
30. 2003) Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 94, 15-21.
< , T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., Haga, N. (https://doi.org/10.1111/j.1349-7006.2003.tb01345.x>
31. 1997) Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin. Int. J. Hyperthermia 13, 251-255.
< , P. R., Landry, J., Storck, C., Davis, K., O’Hara, M. D., Owen, C. S., Leeper, D. B., Coss, R. A. (https://doi.org/10.3109/02656739709023533>
32. 2007) The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. Int. J. Oncol. 31, 1465-1472.
, T., Nakahashi, Y., Hachimine, D., Seki, T., Okazaki, K. (
33. 2005) Cellular processing of platinum anticancer drugs. Nat. Rev. Drug. Discov. 4, 307-320.
< , D, Lippard, S. J. (https://doi.org/10.1038/nrd1691>
34. 2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.
< , H., Matsui, T., Yamamoto, A., Okada, T., Mori, K. (https://doi.org/10.1016/S0092-8674(01)00611-0>
35. 2008) Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol. Res. 38, 474-483.
< , M., Ono, N., Yodono, H., Ichida, T., Nakamura, H. (https://doi.org/10.1111/j.1872-034X.2008.00338.x>
36. 2009) Tunicamycin suppresses cisplatin-induced HepG2 cell apoptosis via enhancing p53 protein nuclear export. Mol. Cell Biochem. 327, 171-182.
< , L. J., Li, Z. Q., Yang, Y. P., Li, X. W., Ji, J. F. (https://doi.org/10.1007/s11010-009-0055-z>